Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Cipla buys four women-focused brands from Mumbai-based Wanbury
Indian pharmaceutical major Cipla Ltd said it has acquired four women-focused nutraceutical products from Mumbai-based drugmaker...
Healthcare
How OrbiMed-backed Eurolife aims to tap into overseas markets for growth
Eurolife Healthcare Pvt. Ltd, which is backed by healthcare-focused private equity firm OrbiMed, aims to double its revenue in...
Healthcare
Ascent Capital invests in drugmaker spun off from SeQuent Scientific
Mid-market private equity firm Ascent Capital has invested in a women-focused drugmaker that was previously part of its portfolio...
Healthcare
InnoVen Capital extends venture debt to VC-backed genomics company
InnoVen Capital has provided venture debt to a healthcare company that had last raised a significant round of equity funding ......
Healthcare
Drugmaker Granules India sells entire stake in Chinese JV
Hyderabad-based drugmaker Granules India Ltd has sold its stake in its Chinese joint venture to its local partner, more than ......
Healthcare
Dr Lal PathLabs to acquire two Maharashtra laboratories
Dr Lal PathLabs Ltd, a Gurugram-based public diagnostics chain, will spend around Rs 7.7 crore (a little over $1 million ......
Healthcare
ChrysCapital returns as investor in another pharma firm after taking it public
Homegrown private equity firm ChrysCapital has returned to invest in a pharmaceutical company that it had helped launch on the...
Healthcare
Budget 2020: Cheer for medical device makers, viability gap funding for hospitals
Finance minister Nirmala Sitharaman in her Budget proposed to impose a cess on the import of medical devices as India ......
Healthcare
How much did CDC Group make by paring stake in hospital chain?
CDC Group Plc, the UK government’s development finance institution, has struck a partial exit from a hospital chain in which...
Healthcare
Temasek stares at massive haircut from Indian pharma investment
Singapore state investor Temasek Holdings is staring at a sharp loss from its nearly five-year-old investment in an Indian drugmaker...
